DRKS00004296已完成不适用
Indication and outcome of hematopoietic stem cell transplantation in primary immunodeficiency with predominant hypogammaglobulinemia – a retrospective study - StemPAD
Centrum für Chronische Immundefizienz (CCI), Universitätsklinikum Freiburg0 个研究点目标入组 31 人开始时间: 2012年8月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 Years 至 99 Years（—）
- 性别
- All
入选标准
- •adult patients with primary immunodeficiency with predominant antibody deficiency having undergone allogeneic hematopoietic stem cell transplantation before 1st january 2013
排除标准
- •age under 2 at transplantation, no informed consent to data collection
研究者
相似试验
招募中
不适用
Outcome of hematopoietic stem cell transplantation in pediatric patient with Thalassemia in ThailandTransfusion dependent thalassemia receiving hematopoietic stem cell transplantatonHematopoietic stem cell transplantation, thalassemia, pediatric, outcome, ThailandTCTR20220905001The Thai Society of Hematology350
已完成
不适用
Indication of allogenic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in first remission: Retrospective analysisAdults with philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in first remissionJPRN-UMIN000016287Chiba Aoba Municipal Hospital100
进行中（未招募）
不适用
Blood stem cell transplantation for patients with relapsiong-remitting multiple sclerosis, in whom standard treatment has failed.Relapsing-remitting multiple sclerosisMedDRA version: 13.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-023560-40-SEppsala l?ns landsting120
招募中
不适用
Clinical Phase II Study of hematopoietic stem ctell transplantation for ataxia telangiectasia and related diseasesataxia telangiectasia DNA damage response disorderJPRN-UMIN000019532Graduate Schoool, Dept. of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University5
进行中（未招募）
1 期
Hematopoietic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized StudyInflammatory Multiple SclerosisEUCTR2012-004165-41-GBorthwestern University